title: [Comparison of treatment results of prostatic cancer between radical prostatectomy and radiation therapy].
abstract: Between 1982 and 1990, 55 patients with prostate cancer (clinical stage A2-C) underwent pelvic lymphadenectomy at the Public Toyooka Hospital. The patients were subsequently treated either by radical prostatectomy (36 cases) or external radiation therapy (19 cases). The age of the patients varied from 56 to 85 (Mean 73.1). The outcome of the 46 patients with negative lymph node (prostatectomy 31, radiation 15) were compared. The 10-year disease-specific survival rates were 100% for the patients treated by prostatectomy and 78% for those treated by radiation (P = 0.035). The 5-year progression-free survival rates for the prostatectomy group and radiation group were 97% and 56%, respectively (P = 0.013). Among the radiation groups, patients with well differentiated carcinoma showed a lower progression rate as compared to those with moderately or poorly differentiated carcinoma (5-year progression-free survival, 81 vs 20%, P = 0.094). The outcome of the 9 patients with positive lymph node (prostatectomy 5, radiation 4) was not satisfactory because of the high progression rates in the two groups (5 year progression-free survival, 30% in prostatectomy and 25% in radiation group).
authors: Department of Urology, Public Toyooka Hospital.
authors: H
authors: H
authors: Kanamaru
authors: Y
authors: Y
authors: Arai
authors: S
authors: S
authors: Moroi
authors: T
authors: T
authors: Shirahase
authors: Y
authors: Y
authors: Isogawa
authors: H
authors: H
authors: Okuno
authors: Y
authors: Y
authors: Kihara
authors: J Y
authors: JY
authors: Kuo
authors: T
authors: T
authors: Taniguchi
authors: H
authors: H
authors: Takeuchi
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D008875:Middle Aged; D011468:Prostatectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery*; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome